Literature DB >> 20408855

T-cell response to viral antigens in adults and children with common variable immunodeficiency and specific antibody deficiency.

L M Haveman1, J Scherrenburg, L J Maarschalk-Ellerbroek, P D Hoek, R Schuurman, W de Jager, P M Ellerbroek, B J Prakken, D van Baarle, J M van Montfrans.   

Abstract

Several T cell abnormalities have been described in common variable immunodeficiency (CVID), a B cell disorder of mainly unknown origin. A subset of CVID patients suffers from frequent reactivations of herpes viruses. We studied T cell function in CVID [and in a subset of paediatric patients with specific antibody deficiency (SAD)] by measuring T cell proliferation and cytokine production in response to herpes virus-antigens in paediatric CVID patients (n=9) and paediatric SAD patients (n=5), in adult CVID patients (n=14) and in healthy controls. Paediatric CVID patients, but not SAD patients, displayed moderately increased CD8+ T cell proliferation in response to cytomegalovirus, human herpes virus type 6B (HHV6-B) and herpes simplex virus compared to controls. CD8+ T cell responses in adult CVID patients tended to be increased in response to cytomegalovirus and herpes simplex virus. In response to stimulation with herpes virus antigens, the proinflammatory cytokines interleukin (IL)-1beta, IL-6, tumour necrosis factor (TNF)-alpha and interferon inducible protein (IP)-10 were produced. Overall, no major differences were detected in cytokine production upon stimulation between patients and controls, although higher IL-10 and IL-12 production was detected in paediatric patients. In conclusion, cellular immunity against herpes virus antigens appears undisturbed in CVID patients, although defects in subpopulations of CVID patients cannot be excluded.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20408855      PMCID: PMC2940155          DOI: 10.1111/j.1365-2249.2010.04159.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  46 in total

Review 1.  Tackling the heterogeneity of CVID.

Authors:  Sigune Goldacker; Klaus Warnatz
Journal:  Curr Opin Allergy Clin Immunol       Date:  2005-12

2.  Novel pan-DR-binding T cell epitopes of adenovirus induce pro-inflammatory cytokines and chemokines in healthy donors.

Authors:  Lianne M Haveman; Marc Bierings; Elisabeth Legger; Mark R Klein; Wilco de Jager; Henny G Otten; Salvatore Albani; Wietse Kuis; Alessandro Sette; Berent J Prakken
Journal:  Int Immunol       Date:  2006-09-05       Impact factor: 4.823

3.  The T cell response to persistent herpes virus infections in common variable immunodeficiency.

Authors:  M Raeiszadeh; J Kopycinski; S J Paston; T Diss; M Lowdell; G A D Hardy; A D Hislop; S Workman; A Dodi; V Emery; A D Webster
Journal:  Clin Exp Immunol       Date:  2006-11       Impact factor: 4.330

4.  Unravelling the complexity of T cell abnormalities in common variable immunodeficiency.

Authors:  Antonello Giovannetti; Marina Pierdominici; Francesca Mazzetta; Marco Marziali; Cristina Renzi; Anna Maria Mileo; Marco De Felice; Barbara Mora; Antonella Esposito; Rossella Carello; Antonio Pizzuti; Marco G Paggi; Roberto Paganelli; Walter Malorni; Fernando Aiuti
Journal:  J Immunol       Date:  2007-03-15       Impact factor: 5.422

5.  Primary immunodeficiency diseases: an update from the International Union of Immunological Societies Primary Immunodeficiency Diseases Classification Committee Meeting in Budapest, 2005.

Authors:  Luigi Notarangelo; Jean-Laurent Casanova; Mary Ellen Conley; Helen Chapel; Alain Fischer; Jennifer Puck; Chaim Roifman; Reinhard Seger; Raif S Geha
Journal:  J Allergy Clin Immunol       Date:  2006-04       Impact factor: 10.793

6.  Detection of antibodies against adenovirus protein IX, fiber, and hexon in human sera by immunoblot assay.

Authors:  Ulrike Bauer; Gisela Flunker; Kornelia Bruss; Knut Kallwellis; Herbert Liebermann; Tanja Luettich; Manfred Motz; Werner Seidel
Journal:  J Clin Microbiol       Date:  2005-09       Impact factor: 5.948

7.  Low numbers of regulatory T cells in common variable immunodeficiency: association with chronic inflammation in vivo.

Authors:  B Fevang; A Yndestad; W J Sandberg; A M Holm; F Müller; P Aukrust; S S Frøland
Journal:  Clin Exp Immunol       Date:  2007-03       Impact factor: 4.330

8.  Defective T-cell activation caused by impairment of the TNF receptor 2 costimulatory pathway in common variable immunodeficiency.

Authors:  Rosa M Aspalter; Martha M Eibl; Hermann M Wolf
Journal:  J Allergy Clin Immunol       Date:  2007-09-07       Impact factor: 10.793

9.  Common variable immunodeficiency disorders: division into distinct clinical phenotypes.

Authors:  Helen Chapel; Mary Lucas; Martin Lee; Janne Bjorkander; David Webster; Bodo Grimbacher; Claire Fieschi; Vojtech Thon; Mohammad R Abedi; Lennart Hammarstrom
Journal:  Blood       Date:  2008-03-04       Impact factor: 22.113

Review 10.  Translational mini-review series on immunodeficiency: molecular defects in common variable immunodeficiency.

Authors:  C Bacchelli; S Buckridge; A J Thrasher; H B Gaspar
Journal:  Clin Exp Immunol       Date:  2007-09       Impact factor: 4.330

View more
  3 in total

Review 1.  Lymphoid proliferations of indeterminate malignant potential arising in adults with common variable immunodeficiency disorders: unusual case studies and immunohistological review in the light of possible causative events.

Authors:  Sara Pereira da Silva; Elena Resnick; Mary Lucas; Jennifer Lortan; Smita Patel; Charlotte Cunningham-Rundles; Kevin Gatter; Qingyan Liu; Elaine S Jaffe; Helen Chapel
Journal:  J Clin Immunol       Date:  2011-07-09       Impact factor: 8.317

Review 2.  Immune response to HHV-6 and implications for immunotherapy.

Authors:  Aniuska Becerra; Laura Gibson; Lawrence J Stern; J Mauricio Calvo-Calle
Journal:  Curr Opin Virol       Date:  2014-10-27       Impact factor: 7.090

Review 3.  Cytokines in common variable immunodeficiency as signs of immune dysregulation and potential therapeutic targets - a review of the current knowledge.

Authors:  Farnaz Najmi Varzaneh; Bärbel Keller; Susanne Unger; Asghar Aghamohammadi; Klaus Warnatz; Nima Rezaei
Journal:  J Clin Immunol       Date:  2014-05-15       Impact factor: 8.317

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.